Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Background and methods: We investigated the factors that determine the best glycaemic control on multiple daily insulin (MDI) injections and continuous subcutaneous insulin infusion (CSII), and the hypothesis that blood glucose variability is a major determinant of control and that the resultant HbA 1c on MDI correlates with the improvement achieved by CSII. We studied 30 type 1 diabetic subjects already receiving MDI. Renewed attempts to improve control on MDI were made for a median of five months, and then the subjects were switched to CSII. The variability of within‐day and between‐day blood glucose concentrations was calculated from blood glucose self‐monitoring data. Results: HbA 1c during MDI varied from 5.7 to 11.7% (mean ± SD, 8.5 ± 1.4%). Within‐ and between‐day blood glucose variability correlated with HbA 1c on MDI (r = 0.59, p < 0.001; r = 0.48, p < 0.03). Within‐day variability remained an independent predictor of HbA 1c on MDI. Mean HbA 1c improved with CSII (to 7.3 ± 0.9%, p < 0.001), but reduction in HbA 1c was variable and was related to the HbA 1c on MDI (r = 0.79, p < 0.001) and within‐day variability (r = 0.56, p < 0.01). Similar results were observed for subjects treated only with glargine‐based MDI. Conclusions: The best glycaemic control achievable on MDI is related to blood glucose variability—those with the largest swings in blood glucose retaining the highest HbA 1c. The improvement in control achieved by CSII is related to HbA 1c and blood glucose variability on MDI. Pump therapy is most effective in those worst controlled on MDI. Copyright © 2006 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90605-w · Cited by 807
Doyle (Boland), E. A., Weinzimer, S. A., Steffen, A. T., Ahern, J. A. H., Vincent, M., & Tamborlane, W. V. (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1554 · Cited by 373
Hermansen, K., Fontaine, P., Kukolja, K. K., Peterkova, V., Leth, G., & Gall, M.-A. (2004) · Diabetologia · doi:10.1007/s00125-004-1365-z · Cited by 365
Bode, B. W., Steed, R. D., & Davidson, P. C. (1996) · Diabetes Care · doi:10.2337/diacare.19.4.324 · Cited by 257
Raskin, P., Klaff, L., Bergenstal, R., Hallé, J. P., Donley, D., & Mecca, T. (2000) · Diabetes Care · doi:10.2337/diacare.23.11.1666 · Cited by 250
Russell-Jones, D., Simpson, R., Hylleberg, B., Draeger, E., & Bolinder, J. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90072-0 · Cited by 194
Linkeschova, R., Raoul, M., Bott, U., Berger, M., & Spraul, M. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00713.x · Cited by 165
Cited by
Pickup, J. C., & Sutton, A. J. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02486.x · Cited by 617
Self-citationGlucose Variability; Does It Matter?
Siegelaar, S. E., Holleman, F., Hoekstra, J. B. L., & DeVries, J. H. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0021 · Cited by 409
Cummins, E., Royle, P., Snaith, A., Greene, A., Robertson, L., McIntyre, L., & Waugh, N. (2010) · Health Technology Assessment · doi:10.3310/hta14110 · Cited by 335
Use of Insulin Pump Therapy in the Pediatric Age-Group
Phillip, M., Battelino, T., Rodriguez, H., Danne, T., Kaufman, F., & participants, F. T. C. F. (2007) · Diabetes Care · doi:10.2337/dc07-9922 · Cited by 316
Insulin-pump therapy for type 1 diabetes mellitus
Pickup, J. C. (2012) · New England Journal of Medicine · doi:10.1056/nejmct1113948 · Cited by 270
Self-citation
Metadata
- Authors
- Pickup, J. C., Kidd, J., Burmiston, S., & Yemane, N.
- Venue
- Diabetes/Metabolism Research and Reviews
- Publisher
- Wiley
- Published
- 2006-01-03
- Volume
- 22
- Issue
- 3
- Pages
- 232-237
- ISSN
- 1520-7552 (ISSN-L)
- 1520-7560
- OpenAlex
- W2021831716
- Cited by
- 112
- References
- 9
- FWCI
- 6.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability. https://app.cochat.ai/papers/10.1002/dmrr.614
- The paper
- Pickup, J. C., Kidd, J., Burmiston, S., & Yemane, N. (2006). Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.614
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.